CSIMarket
 
Omniab Inc   (NASDAQ: OABI)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Omniab Inc's Customers Performance

OABI



 
OABI's Source of Revenues During the corresponding time, Omniab Inc recorded a revenue increase by 244.24 % year on year, sequentially revenue fell by -7.01 %. While revenue at the Omniab Inc 's corporate clients

List of OABI Customers




for the same period Omniab Inc recorded revenue increase by 244.24 % year on year, sequentially revenue fell by -7.01 %.

List of OABI Customers

Omniab Inc's Business Units
License and Milestone Revenue    160.57 % of total Revenue
Service    34.14 % of total Revenue
xPloration revenue    9.06 % of total Revenue
Royalty    3.78 % of total Revenue
Reportable    207.54 % of total Revenue






Omniab Inc's Comment on Sales, Marketing and Customers



The company provides services to large pharmaceutical and biotechnology firms specializing in antibody development, early-stage biotechnology companies, and academic institutions. It offers flexible deal structures and customizable access to its technology platforms to accommodate partner requirements. Its technology portfolio includes OmniRat, OmniDeep, Omni dAb, OmniHub, OmniUltra, and the xPloration Partner Access Program, which support antibody discovery and development as well as peptide therapeutic applications.


  News about Omniab Inc Contracts

OmniAb's xPloration Platform: Unleashing the Power of AI in Antibody Engineering

OmniAb Revolutionizes Antibody Engineering with Innovative xPloration PlatformEmeryville, Calif. - OmniAb, Inc. made a significant impact at the 20th Annual PEGS Boston Summit by unvei...




Omniab Inc’s Comment on Sales, Marketing and Customers


The company provides services to large pharmaceutical and biotechnology firms specializing in antibody development, early-stage biotechnology companies, and academic institutions. It offers flexible deal structures and customizable access to its technology platforms to accommodate partner requirements. Its technology portfolio includes OmniRat, OmniDeep, Omni dAb, OmniHub, OmniUltra, and the xPloration Partner Access Program, which support antibody discovery and development as well as peptide therapeutic applications.








OABI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Omniab Inc 560.26 28.92 -56.11 89
SUBTOTAL 0.00 0.00 0.00 -

Sources: Omniab Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Omniab Inc’s corporate clients.
For your research, we’ve provided 9 tables on Omniab Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.